BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20636026)

  • 1. Interleukins and cancer immunotherapy.
    Yoshimoto T; Morishima N; Okumura M; Chiba Y; Xu M; Mizuguchi J
    Immunotherapy; 2009 Sep; 1(5):825-44. PubMed ID: 20636026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and applications of interleukins in cancer immunotherapy.
    Anestakis D; Petanidis S; Kalyvas S; Nday CM; Tsave O; Kioseoglou E; Salifoglou A
    Int J Mol Sci; 2015 Jan; 16(1):1691-710. PubMed ID: 25590298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor immunotherapy].
    Błoński JZ; Warzocha K
    Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Palliative immunotherapy of cancer].
    Gunsilius E; Clausen J; Gastl G
    Ther Umsch; 2001 Jul; 58(7):419-24. PubMed ID: 11508110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gpnmb/osteoactivin, an attractive target in cancer immunotherapy.
    Zhou LT; Liu FY; Li Y; Peng YM; Liu YH; Li J
    Neoplasma; 2012; 59(1):1-5. PubMed ID: 22017590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 21: combination strategies for cancer therapy.
    Skak K; Kragh M; Hausman D; Smyth MJ; Sivakumar PV
    Nat Rev Drug Discov; 2008 Mar; 7(3):231-40. PubMed ID: 18259184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of tumor immunity by therapeutic monoclonal antibodies.
    Abès R; Teillaud JL
    Cancer Metastasis Rev; 2011 Mar; 30(1):111-24. PubMed ID: 21267767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.
    Floros T; Tarhini AA
    Semin Oncol; 2015 Aug; 42(4):539-48. PubMed ID: 26320059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic immunomodulation.
    Galbraith GM
    Dermatol Clin; 1988 Oct; 6(4):561-8. PubMed ID: 2465856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
    Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
    J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of interleukin-21 immunotherapeutic strategies.
    Cappuccio A; Elishmereni M; Agur Z
    J Theor Biol; 2007 Sep; 248(2):259-66. PubMed ID: 17574601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer treatment: what's ahead?
    Parvez T
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):738-45. PubMed ID: 16300718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological approaches to the treatment of malignant disease.
    Guillou PJ
    J R Coll Surg Edinb; 1988 Feb; 33(1):2-8. PubMed ID: 2458468
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer.
    Ramesh R; Ioannides CG; Roth JA; Chada S
    Methods Mol Biol; 2010; 651():241-70. PubMed ID: 20686970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The host immunological response to cancer therapy: An emerging concept in tumor biology.
    Voloshin T; Voest EE; Shaked Y
    Exp Cell Res; 2013 Jul; 319(11):1687-95. PubMed ID: 23518388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.